These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 17418457)

  • 1. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
    Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
    Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.
    Zhou H; Min J; Zhao Q; Gu Q; Cong H; Li Y; He S
    Vaccine; 2012 Feb; 30(10):1800-6. PubMed ID: 22240340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
    Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
    Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.
    Parmley S; Slifer T; Araujo F
    J Infect Dis; 2002 Feb; 185 Suppl 1():S90-5. PubMed ID: 11865445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II.
    Tan F; Hu X; Luo FJ; Pan CW; Chen XG
    Vaccine; 2011 Mar; 29(15):2742-8. PubMed ID: 21315696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts.
    Nielsen HV; Di Cristina M; Beghetto E; Spadoni A; Petersen E; Gargano N
    Exp Parasitol; 2006 Apr; 112(4):274-9. PubMed ID: 16368092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.
    Rashid I; Hedhli D; Moiré N; Pierre J; Debierre-Grockiego F; Dimier-Poisson I; Mévélec MN
    Vaccine; 2011 Nov; 29(48):8838-46. PubMed ID: 21983362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
    Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
    Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
    Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
    Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
    Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice.
    Zhang G; Huang X; Boldbaatar D; Battur B; Battsetseg B; Zhang H; Yu L; Li Y; Luo Y; Cao S; Goo YK; Yamagishi J; Zhou J; Zhang S; Suzuki H; Igarashi I; Mikami T; Nishikawa Y; Xuan X
    Vaccine; 2010 Oct; 28(45):7243-7. PubMed ID: 20832493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
    Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
    Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.